Fidelity Investments’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64M Buy
14,321,255
+792,889
+6% +$3.69M ﹤0.01% 1343
2025
Q4
$74.4M Sell
13,528,366
-1,065,046
-7% -$5.17M ﹤0.01% 1292
2025
Q3
$47.7M Sell
14,593,412
-1,034,410
-7% -$2.93M ﹤0.01% 1452
2025
Q2
$36.1M Sell
15,627,822
-4,132
-0% -$8.98K ﹤0.01% 1500
2025
Q1
$21.7M Sell
15,631,954
-733,710
-4% -$1.23M ﹤0.01% 1646
2024
Q4
$28.3M Sell
16,365,664
-2,312,863
-12% -$4.8M ﹤0.01% 1608
2024
Q3
$37.5M Sell
18,678,527
-2,532,109
-12% -$5.56M ﹤0.01% 1490
2024
Q2
$47.5M Buy
21,210,636
+1,099,919
+5% +$3.2M ﹤0.01% 1329
2024
Q1
$57.7M Sell
20,110,717
-2,328,407
-10% -$4.85M ﹤0.01% 1276
2023
Q4
$39.7M Sell
22,439,124
-2,088,677
-9% -$4.16M ﹤0.01% 1381
2023
Q3
$77.5M Buy
24,527,801
+23,378,974
+2,035% +$43.7M 0.01% 1084
2023
Q2
$759K Sell
1,148,827
-1,938,511
-63% -$1.4M ﹤0.01% 2544
2023
Q1
$2.46M Sell
3,087,338
-117,584
-4% -$152K ﹤0.01% 2320
2022
Q4
$7.24M Sell
3,204,922
-80,861
-2% -$164K ﹤0.01% 2014
2022
Q3
$6.34M Sell
3,285,783
-9,906
-0.3% -$36K ﹤0.01% 2086
2022
Q2
$12.3M Buy
3,295,689
+868
+0% +$3.44K ﹤0.01% 1861
2022
Q1
$21.5M Sell
3,294,821
-985,673
-23% -$7.37M ﹤0.01% 1754
2021
Q4
$49.9M Sell
4,280,494
-1,478,180
-26% -$22.3M ﹤0.01% 1422
2021
Q3
$107M Buy
5,758,674
+71,058
+1% +$1.35M 0.01% 1075
2021
Q2
$121M Buy
5,687,616
+23,401
+0.4% +$539K 0.01% 1041
2021
Q1
$115M Hold
5,664,215
0.01% 1008
2020
Q4
$148M Buy
5,664,215
+1,456,641
+35% +$31.4M 0.01% 869
2020
Q3
$90.1M Buy
+4,207,574
New +$99M 0.01% 957

Other funds holding TSHA